The contract is for the provision of Long-Acting Reversible Contraception ("LARC") services and HIV Testing services to improve sexual health outcomes by: • Increasing the use of Long-Acting Reversible Contraception (LARC), giving more individuals and families reliable control over their reproductive health. • Contributing to a reduction in the number of unintended pregnancies and terminations including teenage conceptions. • Contributing to reducing health inequalities by improving access to good reproductive health services for vulnerable groups. • Increasing the knowledge of risks associated with STIs and referring clients who may have been at risk of STIs to an appropriate service. • Diagnosing more previously undiagnosed HIV through enhanced testing of at-risk populations, contributing to a reduction in late diagnosis and the associated harm. The contract term duration is 33 months, with an option for a period of extension of another 24 months, through to 31st March 2031. The Council is intending to award this contract under the Direct Award Procedure C of The Health Care Services (Provider Selection Regime) Regulations 2023. The annual contract value at current prices is an estimated £219,000 per annum pro rata (ex VAT), based on the unit costs of service delivery and expected demand, making for a total maximum estimated contact value of £1,040,250 (ex VAT).The contract term duration is 33 months, with a contract start date of July 1st 2026 running through to March 31st 2029. There will be an option to extend the contract for a period of up to 24 months, through to 31st March 2031.

The contract is for the provision of Long-Acting Reversible Contraception ("LARC") services and HIV Testing services to improve sexual health outcomes by: • Increasing the use of Long-Acting Reversible Contraception (LARC), giving more individuals and families reliable control over their reproductive health. • Contributing to a reduction in the number of unintended pregnancies and terminations including teenage conceptions. • Contributing to reducing health inequalities by improving access to good reproductive health services for vulnerable groups. • Increasing the knowledge of risks associated with STIs and referring clients who may have been at risk of STIs to an appropriate service. • Diagnosing more previously undiagnosed HIV through enhanced testing of at-risk populations, contributing to a reduction in late diagnosis and the associated harm. The contract term duration is 33 months, with an option for a period of extension of another 24 months, through to 31st March 2031. The Council is intending to award this contract under the Direct Award Procedure C of The Health Care Services (Provider Selection Regime) Regulations 2023. The annual contract value at current prices is an estimated £219,000 per annum pro rata (ex VAT), based on the unit costs of service delivery and expected demand, making for a total maximum estimated contact value of £1,040,250 (ex VAT).The contract term duration is 33 months, with a contract start date of July 1st 2026 running through to March 31st 2029. There will be an option to extend the contract for a period of up to 24 months, through to 31st March 2031.